New Results
New mechanism-based inhibitors of aspartate transcarbamoylase for anticancer drug development
Zhen Lei, Nan Wang, Biying Wang, Zhifang Lu, Hongwei Tan, View ORCID ProfileJimin Zheng, View ORCID ProfileZongchao Jia
doi: https://doi.org/10.1101/662718
Zhen Lei
1College of Chemistry, Beijing Normal University, Beijing, 100875, China
Nan Wang
1College of Chemistry, Beijing Normal University, Beijing, 100875, China
Biying Wang
1College of Chemistry, Beijing Normal University, Beijing, 100875, China
Zhifang Lu
1College of Chemistry, Beijing Normal University, Beijing, 100875, China
Hongwei Tan
1College of Chemistry, Beijing Normal University, Beijing, 100875, China
Jimin Zheng
1College of Chemistry, Beijing Normal University, Beijing, 100875, China
Zongchao Jia
2Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, Ontario, K7L3N6, Canada
Article usage
Posted June 06, 2019.
New mechanism-based inhibitors of aspartate transcarbamoylase for anticancer drug development
Zhen Lei, Nan Wang, Biying Wang, Zhifang Lu, Hongwei Tan, Jimin Zheng, Zongchao Jia
bioRxiv 662718; doi: https://doi.org/10.1101/662718
Subject Area
Subject Areas
- Biochemistry (11752)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14974)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28097)
- Molecular Biology (11594)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)